Procter & Gamble (NYSE:PG) Price Target Lowered to $189.00 at UBS Group

Procter & Gamble (NYSE:PG - Get Free Report) had its target price dropped by UBS Group from $196.00 to $189.00 in a report issued on Thursday,Benzinga reports. The firm currently has a "buy" rating on the stock. UBS Group's target price points to a potential upside of 17.73% from the company's current price.

Other equities research analysts have also issued research reports about the company. Evercore ISI upped their target price on Procter & Gamble from $180.00 to $183.00 and gave the company an "outperform" rating in a research note on Monday, October 21st. Wells Fargo & Company cut their target price on shares of Procter & Gamble from $190.00 to $176.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Royal Bank of Canada reiterated a "sector perform" rating and set a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research note on Monday, October 21st. Finally, Piper Sandler initiated coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a "neutral" rating and a $174.00 target price for the company. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $180.05.

Procter & Gamble Price Performance

PG traded up $0.89 during trading on Thursday, reaching $160.54. 3,334,298 shares of the stock were exchanged, compared to its average volume of 6,515,655. Procter & Gamble has a 1 year low of $146.28 and a 1 year high of $180.43. The company has a market capitalization of $378.08 billion, a price-to-earnings ratio of 27.68, a P/E/G ratio of 3.41 and a beta of 0.45. The business's 50 day moving average price is $169.40 and its two-hundred day moving average price is $169.52. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm's revenue was down .6% on a year-over-year basis. During the same period in the prior year, the company earned $1.83 EPS. As a group, equities research analysts anticipate that Procter & Gamble will post 6.93 earnings per share for the current year.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the company's stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock valued at $13,317,460 over the last 90 days. 0.18% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC increased its holdings in Procter & Gamble by 7.0% in the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company's stock valued at $9,538,327,000 after buying an additional 3,619,466 shares during the last quarter. FMR LLC increased its holdings in shares of Procter & Gamble by 2.7% in the 3rd quarter. FMR LLC now owns 26,556,319 shares of the company's stock valued at $4,599,554,000 after acquiring an additional 689,282 shares during the last quarter. Legal & General Group Plc lifted its stake in Procter & Gamble by 0.6% during the second quarter. Legal & General Group Plc now owns 21,632,054 shares of the company's stock worth $3,567,556,000 after purchasing an additional 122,190 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Procter & Gamble by 10.2% in the third quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company's stock worth $3,290,573,000 after purchasing an additional 1,760,214 shares during the period. Finally, Fisher Asset Management LLC increased its stake in Procter & Gamble by 4.7% during the third quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company's stock valued at $3,183,522,000 after purchasing an additional 830,476 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.